Johnson & Johnson JNJ:NYSE

RT Quote | Last NASDAQ LS, VOL From CTA | USD

Last | 05/17/24 EDT

151.27

+1.24 (+0.81%)

Volume

6,585,677

52 week range

143.13 - 175.97

Open153.10
Day High153.39
Day Low151.26
Prev Close151.27
52 Week High175.97
52 Week High Date08/10/23
52 Week Low143.13
52 Week Low Date04/18/24

Key Stats

Market Cap364.058B
Shares Out2.41B
10 Day Average Volume6.59M
Dividend4.96
Dividend Yield3.28%
Beta0.54
YTD % Change-3.49

KEY STATS

Open153.10
Day High153.39
Day Low151.26
Prev Close151.27
52 Week High175.97
52 Week High Date08/10/23
52 Week Low143.13
52 Week Low Date04/18/24
Market Cap364.058B
Shares Out2.41B
10 Day Average Volume6.59M
Dividend4.96
Dividend Yield3.28%
Beta0.54
YTD % Change-3.49

RATIOS/PROFITABILITY

EPS (TTM)6.69
P/E (TTM)22.62
Fwd P/E (NTM)14.32
EBITDA (TTM)31.292B
ROE (TTM)24.23%
Revenue (TTM)85.648B
Gross Margin (TTM)69.57%
Net Margin (TTM)19.93%
Debt To Equity (MRQ)48.03%

EVENTS

Earnings Date07/17/2024(est)
Ex Div Date05/20/2024
Div Amount1.24
Split Date-
Split Factor-

Latest On Johnson & Johnson

These are the Dow’s most impactful stocks in its march to the key 40,000 levelMay 16, 2024CNBC.com
These Dow stocks are cheap and have more upside as index reaches key milestoneMay 16, 2024CNBC.com
These stocks with high dividends, strong cash flow could outperform, Wolfe saysMay 13, 2024CNBC.com
Stocks making the biggest moves premarket: GameStop, Nvidia, Intel, KenvueMay 13, 2024CNBC.com
TRADE ALERTWe're exiting a troubled drugmaker and buying 2 stocks with brighter outlooksMay 8, 2024CNBC.com

Content From Our Affiliates

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Johnson & Johnson (JNJ), Eli Lilly & Co (LLY) and Coherus Biosciences (CHRS)21 Hours AgoTipRanks
Ex-Dividend Date Nearing for These 10 Stocks – Week of May 20, 2024May 19, 2024TipRanks
Study links talc use to ovarian cancer, a potential boon for thousands suing J&JMay 18, 2024NBC NEWS
Johnson & Johnson to acquire Proteologix for $850M in cashMay 16, 2024TipRanks
Johnson & Johnson (JNJ) Receives a Buy from RBC CapitalMay 16, 2024TipRanks

Profile

Johnson & Johnson, through its subsidiaries, is engaged in the research and development, manufacture, and sale of a range of products in the healthcare field. The Company’s primary focus is products related to human health and well-being. It operates through two segments: Innovative Medicine and MedTech. The Innovative Medicine segment is focused on various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and...

Joaquin Duato

Chairman of the Board, Chief Executive Officer

Joseph Wolk

Chief Financial Officer, Executive Vice President

Tim Schmid

Executive Vice President, Worldwide Chairman of MedTech

Elizabeth Forminard

Executive Vice President, General Counsel

John Reed M.D., Ph.D.

Executive Vice President - Innovative Medicine, Research and Development

Address

One Johnson & Johnson Plaza

New Brunswick, NJ

08933

United States

https://www.jnj.com/

Top Peers

SYMBOL	LAST	CHG	%CHG
MRK Merck & Co Inc	130.99	UNCH	UNCH
ABBV AbbVie Inc	164.56	UNCH	UNCH
AZN AstraZeneca PLC	77.11	UNCH	UNCH
RHHBY Roche Holding AG	32.77	-0.04	-0.12%
NVS Novartis AG	102.84	UNCH	UNCH